Literature DB >> 2774644

The Ki-67 antigen in primary human melanomas--its relationship to mitotic rate and tumor thickness and its stability.

H Ostmeier1, L Suter.   

Abstract

We investigated whether two parameters of proliferative activity - mitotic rate and Ki-67 positive cells - are interchangeable. The mitotic rate was assessed on paraffin-embedded sections, Ki-67 positive cells were immunohistologically determined in frozen tissue. A poor correlation (correlation coefficient r = 0.57) was found between both parameters. The proliferative activity was often not homogeneously distributed in the tested tumors. However, this is a major reason for the observed difference only in thin melanomas (less than 1.5 mm) as seen by comparison of tumors with homogeneous and inhomogeneous proliferative activity. We assume that arrest of cells in different stages of the cell cycle - variable from melanoma to melanoma - is the major reason for the observed discrepancy between mitotic rate and Ki-67 positive cells in tumors of 1.5 mm and thicker. The mean number of Ki-67 positive cells increased with tumor thickness. The stability of the Ki-67 antigen towards freezing, thawing, and formalin was studied.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774644     DOI: 10.1007/BF00456388

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  19 in total

1.  Analysis of object clustering.

Authors:  M W Buser; M Oberholzer; H Christen; P U Heitz
Journal:  Anal Quant Cytol Histol       Date:  1987-08       Impact factor: 0.302

2.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

3.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

4.  Factors associated with death from melanoma from 2 to 5 years following diagnosis in clinical stage I patients.

Authors:  A J Sober; C L Day; T B Fitzpatrick; R A Lew; A W Kopf; M C Mihm
Journal:  J Invest Dermatol       Date:  1983-06       Impact factor: 8.551

5.  Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

Authors:  J Gerdes; R J Lelle; H Pickartz; W Heidenreich; R Schwarting; L Kurtsiefer; G Stauch; H Stein
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

6.  Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phase.

Authors:  B Drewinko; L Y Yang; B Barlogie; J M Trujillo
Journal:  Cell Tissue Kinet       Date:  1984-09

7.  Prognostic index in malignant melanoma.

Authors:  C Schmoeckel; O Braun-Falco
Journal:  Arch Dermatol       Date:  1978-06

8.  The proliferative activity of cells of malignant melanomas.

Authors:  G E Pierard; C Pierard-Franchimont
Journal:  Am J Dermatopathol       Date:  1984       Impact factor: 1.533

9.  Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

Authors:  C L Day; M C Mihm; R A Lew; M N Harris; A W Kopf; T B Fitzpatrick; T J Harrist; F M Golomb; A Postel; P Hennessey; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; D Rigel; R J Friedman; M M Mintzis; A J Sober
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

10.  Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.

Authors:  C Kuehnl-Petzoldt; H Keil; E Schoepf
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

View more
  4 in total

1.  The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas.

Authors:  H Ostmeier; J Schumann; F Otto; V Krieg; B Fuchs; B Biess; G Burg; L Suter
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  p-glycoprotein expression in malignant melanoma.

Authors:  B Fuchs; H Ostmeier; L Suter
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  Comparison of proliferation rates assessed using "multiblock" and conventional tissue blocks of lung carcinoma.

Authors:  D C Brown; K C Gatter
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

4.  The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.

Authors:  R Schröder; K Bien; R Kott; I Meyers; R Vössing
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.